The immune system is a dynamic, data-rich network shaped by disease, treatment, and time. Omniscope makes sense of this complexity through our foundational model of the immune system.
Omniscope's foundational model uncovers core principles of immune response and optimal cellular therapy design — accelerating drug discovery and disease diagnosis across cancer, autoimmune, infectious, and neuroimmune diseases.
We deliver insights for:
Predicting treatment response
Stratifying patients
Tracking immune dynamics
In-silico therapy design
Whether in drug development or clinical strategy, Omniscope powers a new era of precision immunology by placing the immune system at the heart of therapeutic success.
Single-cell resolution T cell receptor profiling for therapeutic development.
Single-cell resolution B cell receptor profiling for therapeutic antibody design.
Single-molecule resolution for precise, quantitative T cell receptor profiling.
Single-molecule resolution for quantitative B cell receptor profiling.
Omniscope immune portal provides comprehensive computational models to interrogate the immune system at cellular level.
Omniscope immune databank built across populations, indications and outcomes.
End-to-end generative pipeline for TCR-T design.
New product release soon.
Stay tuned.
Experience the power of single-molecule resolution for deep, quantitative, and cost-efficient profiling of T and B cell repertoires.
Track clonotypes to identify and monitor immunotherapy response.
Leverage single-molecule resolution for deep, quantitative, and cost-efficient profiling of T and B cell repertoires.
Determine which patients are likely to benefit from your drug.
Leverage single-molecule resolution for deep, quantitative, and cost-efficient profiling of T and B cell repertoires.
Discover patient populations that are at risk of adverse reactions with your drug.
Experience the power of single-cellular resolution for deep, quantitative, and qualitative profiling of T and B cell repertoires.
Accelerate your therapy development by identifying and testing (in silico & in vitro) novel candidates for advanced cell therapy.
...identify disease associated signatures.
...predict therapy response.
...guide therapeutic discovery.
...support cellular engineering.